In this report, the global Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs in these regions, from 2013 to 2025 (forecast), covering
Global Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy’s Laboratories Ltd.
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Akynzeo (Netupitant-Palonosetron FDC)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
SUSTOL (Granisetron Injection extended release)
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
If you have any special requirements, please let us know and we will offer you the report as you want.
We will be happy to help you find what you're looking for. Please email us